The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...

Flow’s headset is the first tDCS device approved by the FDA ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...

A headset that stimulates the brain with electricity is able to relieve symptoms of major depression in 57.5% of patients, a new trial has found. Researchers at Kings College London studied 174 ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

In the study, "A wearable repetitive transcranial magnetic stimulation device," published in Nature Communications, researchers developed and tested a portable brain stimulation system by combining ...

A home-based brain stimulation device appeared to boost cognition in patients with early Alzheimer's disease (AD), although the effect was small, a new study showed. Patients who received active ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...